RVL Pharmaceuticals plc Proceeds from Issuance Initial Public Offering
RVL Pharmaceuticals plc reported Proceeds from Issuance Initial Public Offering of $36.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2022-11-10
- 2021-09-30: Proceeds from Issuance Initial Public Offering 9 month $36.00K.
| Period end | Proceeds from Issuance Initial Public Offering 9 month |
|---|---|
| 2021-09-30 | $36.00K 10-Q · filed 2022-11-10 |